Auna S.A. (NYSE:AUNA) Receives Consensus Recommendation of "Hold" from Analysts

Key Points

• Consensus "Hold": Five analysts give Auna a consensus rating of Hold — comprising one sell, two holds, one buy and one strong-buy — with an average 12‑month target price of $7.30.
• Valuation and share price: AUNA opened at $5.20, trades in a 52‑week range of $4.46–$7.39, has a market cap of about $384.5M and a P/E of 14.43.
• Recent results and outlook: Last quarter Auna reported EPS of $0.53 on revenue of $596.6M, and analysts expect roughly $0.87 EPS for the current fiscal year.

Auna S.A. (NYSE:AUNA - Get Free Report) has been assigned a consensus rating of "Hold" from the five ratings firms that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, one has assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $7.30.

AUNA has been the topic of several research analyst reports. HSBC upgraded Auna from a "hold" rating to a "buy" rating and set a $6.90 target price on the stock in a report on Wednesday, January 21st. Zacks Research cut Auna from a "strong-buy" rating to a "hold" rating in a report on Tuesday, March 31st. Jefferies Financial Group initiated coverage on Auna in a report on Friday, January 16th. They set a "buy" rating and a $9.00 target price on the stock. Weiss Ratings restated a "sell (d)" rating on shares of Auna in a report on Friday, March 27th. Finally, Wall Street Zen upgraded Auna from a "buy" rating to a "strong-buy" rating in a report on Saturday, February 28th.

Auna Price Performance

Shares of AUNA stock opened at $5.20 on Friday. The stock's fifty day moving average is $5.38 and its 200-day moving average is $5.24. The company has a debt-to-equity ratio of 1.87, a quick ratio of 1.01 and a current ratio of 1.11. The stock has a market capitalization of $384.48 million, a PE ratio of 14.43 and a beta of 1.63. Auna has a 52 week low of $4.46 and a 52 week high of $7.39.

Auna (NYSE:AUNA - Get Free Report) last announced its earnings results on Saturday, February 14th. The company reported $0.53 EPS for the quarter. The company had revenue of $596.55 million for the quarter. Auna had a return on equity of 19.23% and a net margin of 2.13%. Equities research analysts expect that Auna will post 0.87 EPS for the current fiscal year.

Hedge Funds Weigh In On Auna

Hedge funds have recently added to or reduced their stakes in the company. XTX Topco Ltd bought a new position in Auna in the fourth quarter valued at about $162,000. Occudo Quantitative Strategies LP bought a new position in Auna in the fourth quarter valued at about $84,000. Millennium Management LLC boosted its holdings in Auna by 115.2% in the fourth quarter. Millennium Management LLC now owns 26,475 shares of the company's stock valued at $130,000 after acquiring an additional 14,170 shares during the last quarter. Squarepoint Ops LLC bought a new position in Auna in the fourth quarter valued at about $196,000. Finally, Heron Bay Capital Management bought a new position in Auna in the fourth quarter valued at about $138,000.

Auna Company Profile

Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna's organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.

The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.